
04 Apr 2023 Wellbeing
£200 grants for people affected by leukaemia once again available
Leukaemia UK and Leukaemia Care have this month relaunched the ‘Cost of Living Fund’, providing financial grants of £200 to patients with leukaemia, myelodysplastic syndrome (MDS) or myeloproliferative neoplasms (MPNs), whose lives have been impacted by the ongoing cost of living crisis.
Applications are open now for grants of up to £200 provided by the Leukaemia UK and Leukaemia Care ‘Cost of Living Fund’. Over £168,000 was given to families affected by leukaemia, MDS or an MPN in 2022. Together, Leukaemia UK and Leukaemia Care hope that the relaunch of this fund will provide much-needed support during one of the most difficult times of a person’s life.
Fiona Hazell, Chief Executive of Leukaemia UK, said:
“The relaunch of the Cost of Living with Leukaemia Fund will help to improve the lives of more people across the UK living with leukaemia. The emotional and physical challenges of leukaemia are profound, and the diagnosis often brings additional financial pressures during what is already one of the most difficult times of a person’s life. The Cost of Living with Leukaemia Fund will make a tangible difference to their lives, and we are very grateful to our supporters for making this relaunch possible.”
Please visit the Leukaemia Care website to find out more.
Related posts
21 May 2020
A new clinical trial announced
A study into the impact of severe covid-19 infection on patients who receive stem cell transplants for blood cancers and blood disorders.
16 November 2023
Leukaemia UK appoints Hannah Peckham as newest Ambassador
Leukaemia UK has today announced its appointment of award-winning children’s book author, Hannah Peckham, as its newest celebrity Ambassador. Hannah joins the likes of actor Dougray Scott, celebrity chef Francesco…
27 August 2020
Leukaemia UK appoints new CEO
The trustees of Leukaemia UK are delighted to announce that they have appointed Fiona Hazell as CEO of Leukaemia UK. Fiona brings a strong track record in not-for-profit leadership, starting her role on 9th September 2020.
11 March 2022
Inquiry highlights the impact of COVID-19 on blood cancer services
A new report has recently been published, following an inquiry by the All-Party Parliamentary Group (APPG) on Blood Cancer and the APPG on Stem Cell Transplantation and Advanced Cellular Therapies, on the impact of Covid-19 on blood cancer services in the UK.